Li Wang

USPTO Granted Patents = 9 (Patent Applications = 8)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 97(Granted Patents)

Company Filing History:

King's College London

patents

where one patent can have more than one assignee

Years Active: 2012-2024

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12064463 - Vista antagonist and methods of use (2024-08-20),

2. 11752189 - Vista antagonist and methods of use (2023-09-12),

3. 11414490 - Regulatory T cell mediator proteins and uses thereof (2022-08-16),

4. 11123426 - Use of vista agonists and antagonists to suppress or enhance humoral immunity (2021-09-21),

5. 10933115 - VISTA antagonist and methods of use (2021-03-02),

6. 10035857 - Regulatory T cell mediator proteins and uses thereof (2018-07-31),

7. 9217035 - Regulatory T cell mediator proteins and uses thereof (2015-12-22),

8. 8501915 - Regulatory T cell mediator proteins and uses thereof (2013-08-06),

9. 8231872 - Regulatory T cell mediator proteins and uses thereof (2012-07-31),

Title: The Innovative Contributions of Li Wang

Introduction

Li Wang is a prominent inventor based in Norwich, Vermont, known for his significant contributions to the field of biotechnology. With a total of nine patents to his name, Wang has made remarkable strides in developing therapeutic solutions that address critical health issues.

Latest Patents

One of Wang's latest patents is focused on a VISTA antagonist and methods of use. This invention is directed to a peptide, multimer, conjugate, analog, derivative, or mimetic that inhibits the activity of VISTA. The therapeutic applications of this VISTA antagonist include treating or preventing cancer, bacterial infections, viral infections, parasitic infections, and fungal infections. Additionally, the invention contemplates research uses of the antagonist, showcasing its potential impact on both clinical and laboratory settings.

Career Highlights

Throughout his career, Li Wang has worked with esteemed institutions such as Dartmouth College and King's College London. His work in these prestigious organizations has allowed him to collaborate with leading experts in the field, further enhancing his innovative capabilities.

Collaborations

Wang has had the opportunity to work alongside notable colleagues, including Randolph J. Noelle and Sabrina Ceeraz. These collaborations have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Li Wang's innovative work in biotechnology, particularly his development of the VISTA antagonist, highlights his commitment to addressing significant health challenges. His contributions continue to pave the way for future advancements in therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.